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LABORATORY INVESTIGATION
Proximal tubule dopamine histofluorescence in renal slices
incubated with L-dopa
JACQUELINE HAGEGE and GABRIEL RICHET
INSERM Unit 64 and Claude Bernard Association, Nephrology Service, Tenon Hospital, Paris, France
Proximal tubule dopamine histofluorescence in renal slices incubated
with L-dopa. Renal cortex slices were incubated with amine precursors
L-dopa, or L-5-HTP. Localization of synthesized amines, dopamine or
serotonin, was examined by means of histofluorescence methods.
Formaldehyde-induced fluorescence was present in the proximal con-
voluted tubule and not in the pars recta or other segments of the tubules
after incubation in the presence of i0- to i0 M L-dopa. Tubule-
induced fluorescence was not seen in the presence of an inhibitor of
dopa-decarboxylase or in the absence of sodium. It was independent of
innervation. It is concluded that dopamine and serotonin are ac-
cumulated and likely formed within proximal convoluted tubular cells.
Histofluorescence do La dopamine dans Ic tube proximal de tranches de
rein incubées avec de Ia L-dOpa. Des tranches de cortex renal ont Cté
incubées avec precurseurs d'amines L-dopa ou L-5-HTP. Les amines
synthetisées, dopamine ou sérotonine, ont été localisées par
histofluorescence. Une fluorescence induite par le formol a été
observée dans les cellules du tube contourne proximal et non dans Ia
pars recta ou les segments tubulaires en aval apres incubation en
presence de i0 a l0- M L-dopa. Cette fluorescence induite n'est plus
observée après addition d'un inhibiteur de Ia dopa-decarboxylase ou en
l'absence de sodium. Elle est indépendante de l'innervation. On en
déduit que les cellules tubulaires proximales peuvent accumuler et
vraisemblablement synthetiser de la dopamine et de la sérotonine.
Dopamine is synthesized by kidney slices incubated with 100
zmoles L-dopa medium at a rate of 2.2 mmoles/hr '/mg of
proteins [1]. In identical conditions isolated glomeruli produce
0.2 and cytosolic fraction 43 mmoles hr '/mg of proteins,
assuming that most of the synthesized dopamine comes from
tubular cells. These results should thus be added to two other
points of evidence for an extraneuronal source of renal do-
pamine: (1) tubular cell location of L-dopa decarboxylase [2, 31;
(2) transformation into dopamine of L-dopa injected into proxi-
mal tubular lumen of denervated kidneys [4]. The present study
deals with the localization of dopamine by histofluorescence in
rat kidney slices incubated in vitro in identical conditions to
those used in biochemical studies [11. To a certain extent
serotonin formation was also morphologically sought. Mor-
phologic evidences indicate that extraneuronal synthesis of
dopamine and serotonin exists in the rat kidney, occurring
exclusively in the proximal convoluted tubule.
Methods
ucts Division, North Chicago, Illinois, USA) 5 mg/lOO g body
wt. The kidneys were perfused in situ with oxygenated physi-
ologic solution S via an intraortic catheter, and then removed.
Cortical slices approximately 300-tm thick were prepared with
a Stadie-Riggs microtome and cut into 1- to 3-mg fragments.
Incubation procedure. Cortical slices were incubated in a
buffered isotonic solution S (NaCI 130 mM, KCI 5 mM, MgSO4
1 mivi, CaCI2 1 mrvi, NaCh3COO 10 mM, glucose 5 mM,
NaH2PO4 5 mM, adjusted pH 7.4) [5]. Roughly the protein
content was 3 to 4 mg for 50 ml of medium. Incubation was
carried out at 20 to 22°C with oxygen bubbling from below
during 10, 20, 30, or 60 mm to avoid interference with spontane-
ously occurring morphological changes [6]. i-dopa and L-5
hydroxytryptophane l0 to l0- (Sigma Chemical Co., St.
Louis, Missouri, USA) was added from experimental flasks.
Nialamide, 0.4 mg/ml (Sigma Chemical Co.), was sometimes
used as a monoaminoxydase inhibitor. Sodium chloride was
replaced by equimolar amounts of choline chloride in experi-
ments with sodium poor medium.
In vivo treatment. Prior to perfusion and nephrectomy some
rats were submitted to one of the following procedures: (1)
injection of an inhibitor of dopadecarboxylase, benserazide (Ro
044602 Roche) 150 mg/kg of body wt i.p. 1 hr before anesthesia;
(2) injection of nialamide 25 mg/kg of body wt i.p. 2 hr before
anesthesia; (3) denervation of left kidney with alcohol solution
of phenol applied on the renal artery [7] or chemical denerva-
tion by injection of 6-hydroxydopamine (Sigma Chemical Co.)
100 mg/kg of body wt 24 hr before anesthesia.
Fluorescence microscopy. The histological demonstration of
aromatic monoamines and related compounds were performed
by means of their formaldehyde or glyoxylic acid-induced
fluorescence (see review, [8]). As a rule the procedure used was
that of Falck et al reported in 1962 [91. On occasion the
techniques of Loren et al [10] or de la Tone and Surgeon [11]
and de Ia Torre [12] were used (Table 1). For a better discrimi-
nation of induced histofluorescence from autofluorescence the
test of Staple and Luborsky-Moore [13] was used; this tech-
nique consists of suppressing the induced histofluorescence by
NaBH4. The procedure of Lindvall et al [14] was used to
differentiate the fluorescence of dopamine from that of L-dopa
Tissues. Sprague-Dawley male rats weighing 180 to 200 g
(Jeanvier-Le Genet-France) were anesthetized with sodium
pentobarbital (Nembutal ,® Abbott Laboratories Hospital Prod-
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Table 1. Histofluorescence methods
[9] No fixation
Fixation Freezing
Paraformaldehyde 3.5% liquid
Glyoxylic acid 2% nitrogen
MgSo4 30%, pH 5
Freeze-
drying
—70°C
102 mm Hg
24 hr
HCHO vapors
50 to 80%
Relative humidity
60 mm
80°C
Vacuum
embedding
paraffine
or araldite
Sections
2 to 7 p.m
Entellan
mounting[10]
[12] Freezing
—30°C
Cryostat
sections
8 to 10 p.m
Glyoxylic acid 1%, few sec
Sucrose-phosphate buffer, pH = 7.4
Drying cold air, 3 mm 95°C
Mineral
oil
mounting
Table 2. Induced fluorescence in proximal convoluted tubule of slices incubated 30 mm with l0 M L-dopa: procedure of Lindvall et al [141
for identification of dopamine
F F F F GA
Treatment of 50.80% RH 50.80% RH Dry Dry
freeze-dried 80°C 80°C 4°C 4°C 95°C
slices 30 mm 30 mm
GA
95°C
3mm
30 mm 30 mm
GA
95°C
3mm
3 mm
Induced ++ ++± 0
fluorescence
PCT
Abbreviations: F, formaldehyde vapor; GA, glyoxylic acid vapor; RH, relative humidity; PCT, proximal convoluted tubule.
and norepinephrine, According to these authors dopamine was
considered to be present when a positive fluorescence was
induced with warm formaldehyde at 50 to 80% humidity but not
with dry-cold formaldehyde vapor followed by glyoxylic acid
treatment (Table 2). The sections were mounted in Entellan and
examined in a fluorescence microscope (Carl Zeiss, Jena,
Oberkochen, Federal Republic of Germany) fitted with a HBO
200 lamp in epiillumination with excitation filter B 23 g and
barrier filter C 249. Photographs were taken with Ilford HPS
film.
Histo-autoradiography. Slices were incubated in S medium
containing 0.1, 0.01, or 0.001 p.Ci/mI of L-3,4 dihydroxyphenyl
[3-'4C] alanine, Radiochemical Center Amersham (sp act 92
mCilmM). The times of incubation were 5, 10, or 30 mm. After
rinsing with S medium they were processed according to Falck
et al [9] to control formaldehyde-induced fluorescence. Simul-
taneously, neighboring sections were covered with the nuclear
emulsion Ilford G-5 [15]. Time exposure was 2, 5, 10, or 20 days
at 4°C.
Results
Tubular autofluorescence
In proximal convoluted tubules of control slices, incubated in
S medium without substrate, a high green or yellow autofluo-
rescence is present. It predominates at the basal pole in the
form of bodies, likely located inside lysosomes, and remains
unchanged after treatment with formaldehyde vapor. It also
does not change when L-dopa is added to the medium.
Autofluorescence becomes diffuse when kidney slices are
treated with aqueous solution. Moreover, in cryostat sections,
as used by de Ia Torre [12], it is not preserved as well as when
the freeze-drying technique is used. We utilized the latter. In
pars recta autofluorescence is less deep as granules are smaller.
There is no obvious autofluorescence in glomeruli, distal con-
voluted tubule, or collecting ducts.
Formaldehyde-induced tubular fluorescence
Controls. Formaldehyde vapor neither modifies autofluores-
cence nor induces any fluorescence within proximal convoluted
tubule cells in control slices incubated in S medium with or
without nialamide (Fig. 1). Outside the epithelial cells, formal-
dehyde vapor induces the usual fluorescence of adrenergic
nerve plexuses just around the arterial walls.
L-dopa-incuhated slices. In the proximal convoluted tubular
cells, warm and humid formaldehyde vapor induced many
green fluorescent granules, prevailing at the apical pole (Fig. 2).
Cytoplasm was diffusely and faintly fluorescent. At reverse no
fluorescence was revealed in the pars recta, distal convoluted
tubules and collecting ducts, except here and there in the form
of a discrete irregular edge within the lumen, along its brim.
Differentiation between auto- and induced fluoresence.
These two cannot be mistaken. The former is basal, the latter
apical; induced fluorescence vanishes after treatment with
sodium borohydride, autofluorescence does not.
Induced fluorescence corresponds to dopamine deposits.
When formaldehyde vapor is dry and cold, fluorescence is not
induced and that result remains negative even after a sub-
sequent exposure to glyoxylic acid vapor at 95°C (Table 2).
Thus, it fits the typical criteria for dopamine as specified by
Lindvall et a! [14]. Moreover, induced fluorescence is pre-
vented by prior administration of 150 mg/kg of body wt of
benserazide to the rats, a potent L-dopa decarboxylase inhibitor
(Fig. 3). At reverse it is brighter, as far as it could be assessed,
'4
Renal intracellular monoamines 5
Fig. 1. Slice of cortex incubated 30 mm in substrate-free S medium.
Notice the fluorescent granules at the basal pole of proximal convoluted
tubular cells. Distal tubular cells are not fluorescent. The same aspect is
observed without formaldehyde; it corresponds to autofluorescence.
(Freeze-dried, formaldehyde vapor, x 800)
Fig. 2. Slice of cortex incubated 30 ,nin in S medium with I0 M
L-dopa. Formaldehyde induced many fluorescent granules at the apical
pole of proximal convoluted tubular cells (arrows). (Same technique as
in Fig. 1, x800)
by a potent monoaminoxidase inhibitor, nialamide, given before
sacrifice and added to the incubation medium. These two
enzyme inhibitors do not interfere with autofluorescence.
Factors influencing proximal convoluted tubule induced fluo-
rescence. L-dopa concentration is critical. At i07 M induced
fluorescence is very weak, disputable. Time is less important a
factor. At iO' M a faint induced fluorescence appears after 10
mm. It increases and reaches a plateau at 30 mm. At last sodium
is absolutely a necessary cation. No fluorescence can be
obtained if sodium chloride is replaced by choline chloride;
sodium concentration is then as low as 15 m (Fig. 4). At
reverse prior denervation does not intervene; whatsoever the
technique for denervation used, chemical or pharmaco-
logical, induced fluorescence remains unchanged, as does
autofluorescence.
L-5 HTP incubated slices. When L-5 HTP is added to the
medium instead of L-dopa a formol-induced fluorescence could
Fig. 3. Slice of cortex incubated 30 mm in S medium with i0 M
L-dopa. The rat was treated by benserazide, an inhibitor of
dopadecarboxylase. Basal fluorescence only is disclosed, as in Figure 1.
(Same technique as in Figs. I and 2, x800)
Fig. 4. Slice incubated in a S medium in which sodium chloride has been
replaced with choline chloride and with 10 M L-dopa. No induced
tubular fluorescence was observed at the apical pole. Basal fluores-
cence is disclosed corresponding to autofluorescence as in Figures I
and 3. (Freeze-dried, formaldehyde vapor, >K 1000)
be disclosed. It is yellow and not very bright and is located at
the same place as dopamine, that is, at the apical pole of the
proximal convoluted tubule cells. It is not surprising as purified
dopadecarboxylase is known to transform L-5 hydroxy-
tryptophane into serotonin [16].
Histo-autoradiography
A strong labelling of proximal tubules was induced in cortical
slices incubated in S medium added with L-[3-'4C1-dopa. Silver
granules are numerous in the apical pole of proximal tubular
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Fig. 5. Autoradiography of a slice incubated 30 mm with '4C L-dOpa
(0.01 p.1/mi). Proximal convoluted tubule (PCT) are strongly and exclu-
sively labelled; DT represents distal tubule. (xl000)
cells (Fig. 5) after a 30-mm incubation with 0.01 p.Ci/ml.
Glomerulus and distal tubules show very poor labeling, if any.
Discussion
How specific for dopamine is formaldehyde-induced fluores-
cence? Indeed, there is some uncertainty as L-dopa, added to S
milieu, could exhibit a slight formaldehyde-induced fluores-
cence. However, there are strong arguments suggesting that
dopamine and not L-dopa accounts for formaldehyde-induced
fluoresence: (1) Benserazide abolishes it although it does not
impede the penetration of labelled material into the cells when
tagged L-dopa was given simultaneously with the dopa
decarboxylase inhibitor [17]. (2) The lack of formaldehyde-
induced fluorescence under decarboxylase inhibition could not
be an artefact due to physico-chemical conditions suppressing
the histological reaction as dopamine synthesis could not be
demonstrated biochemically [1]. (3) The test of Lindvall et al
accurately fits with that recognized to agree with dopamine and
not with L-dopa or norepinephrine [14]. One should then
assume that the reason why—in some experimental conditions
and in some tubular segments no formaldehyde-induced fluo-
rescence was disclosed—is most likely that dopamine was not
present.
Specificity of the procedure revealing serotonin. L-5
hydroxytryptophane does not become fluorescent when ex-
posed to formaldehyde vapor and serotonin does [18], One can
then be sure that the fluorescence disclosed by formaldehyde
vapor in proximal tubular cells of kidney slices incubated with
L-5 hydroxytryptophane is not due to accumulation of substrate
and that serotonin, most probably, is the fluorescent material.
These data strongly support the intracellular transformation of
L-dopa into dopamine because the same enzyme, dopadecar-
boxylase, is involved in both cases.
Does the sensitivity of the method apply to the detection of
intracellular dopamine and serotonin? Two points should be
discussed. One is the threshold of sensitivity. It has never been
determined as far as dopamine and serotonin are concerned.
However, one can recall the figures obtained with norepineph-
rifle (NE). In vitro the threshold concentration is to 5 p.g/g1.
However, according to Fuxe and Jonsson [8], the NE store as
low as 5. l0— pg can be detected in a single varicosity of nerve
terminal because it is concentrated in a very narrow space. One
can then admit that the positive results obtained in the proximal
convoluted tubule cells, at their apical pole, correspond to a
comparable accumulation. The second point is the tremendous
excess of substrate that creates obviously artificial conditions,
although the appearance of formaldehyde-induced fluorescent
granules in proximal convoluted tubule cells contrasts with the
negative response of cells in other segments of the nephron.
How does L-dopa penetrate the proximal convoluted tubule
cells? The presence of tagged material within the proximal cells
of incubated slices (Fig. 5) demonstrates that L-dopa entered in
the absence of glomerular filtration. It penetrated along with
sodium since dopamine was not formed when choline chloride
replaced sodium chloride. It fits into the usual transport system
of amino acids coupled with sodium transfer. Whether in vitro
L-dopa penetrates the apical pole or the basolateral membrane
is undetermined. Actually, in vivo exists both ways [4, 17]. It is
generally accepted that in kidney slices, intracellular penetra-
tion of an added substance to the bathing milieu takes place
more slowly compared to separated renal tubules [19], at a rate
dependent on oxygen availability [20] and preferentially at the
basolateral membrane [21].
How do the present observations aid interpretation of do-
pamine production by the kidney? A renal production of do-
pamine was ascertained in rats [22] and dogs [23] given L-dopa
(see [241 for review). Moreover, a part of plasma dopamine
could originate from the kidney [25, 26]. Recently, Ball, Gunn,
and Gouglas [27] reported that in dog endogenous plasma
DOPA is extracted and dopamine formed within the kidney.
Doparnine is secreted into the renal vein and to a lesser extent
excreted in urine. It is usually accepted that renal dopamine
comes from neuronic ends either adrenergic [28—30] or
dopaminergic [26, 31—33]. However, our results show that in
kidney slices incubated with i-dopa dopamine is histologically
extraneuronal, intracellular, and strictly localized in segments
SI and S2 of proximal tubules, in innervated as well as in
denervated kidneys, which agrees with data of Baines and Chan
[4]. Using micropuncture techniques Baines and Chan localized
an extraneuronal production of dopamine in the proximal
convoluted tubule of denervated kidney that could account for
at least 30% of the urinary dopamine. Dopamine accumulates in
proximal tubules. Most likely, it is also formed within these
cells under the action of DOPA decarboxylase. However, the
precise localization of this enzyme in the cortex has not been
definitely established. To our knowledge, the only attempt was
that of Goldstein, Fuxe, and Hökfelt [2] who wrote ". . . a
strong immunofluorescence was observed in the distal and
proximal tubule" without presenting data to support that state-
ment. Therefore, a secondary accumulation in proximal cells
•1 0'a
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cannot be excluded. Nevertheless, the concentration of do-
pamine in the milieu during similar incubation performed in the
same laboratory was 5.108 [I]; we checked to see if
histofluorescence for dopamine was negative in tubular cells,
proximal, or distal, when dopamine was added to a L-dopa-free
incubating milieu at 10-6 M final concentration. Thus, dopamine
is either not formed in distal tubular cells or formed and
immediately released.
How do these observations fit with the physiologic effects of
dopamine? L-dopa perfusion has a phosphaturic effect said to
be related to a renal synthesis of dopamine [34J. Of interest is
the fact that both inorganic phosphate reabsorption and intra-
cellular dopamine production take place in the same cells, those
of the proximal convoluted tubule [35]. Dopamine could inhibit
phosphate reabsorption in the place where it is synthesized.
Dopamine and sodium excretion are certainly related, at least
when pharmacological doses are used [26, 30, 36—401. How
dopamine exerts its natriuretic action at that time is unclear. Its
vasoactive effect is considered to be the main one (see [24] and
[41] for review). On the other hand, a direct tubular natriuretic
action is still undetermined [42]. However, recent observations
have brought important evidence favoring such a mechanism
[431. Using in vitro perfusion of rabbit isolated segments of
proximal tubules Bello-Reuss, Higashi, and Kaneda [44] dem-
onstrated that dopamine decreased sodium reabsorption exclu-
sively in the pars recta of the proximal tubule. Dopamine is only
active when added to the milieu bathing the basal pole of the
cells. Indeed, dopamine synthesized within the cells of SS2 can
diffuse into the interstitium [45] and then be easily driven by the
peritubular capillary net to the basal pole of the pars recta cells,
on its way to the renal vein where its concentration is higher
than in the renal artery [27].
Reprint requests to Dr. G. Richet, Service de Néphrologie, Hopital
Tenon 4, rue de Ia Chine, 75970 Paris Cedex 20, France
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